Redmile Group, LLC
CIK 0001425738
Annualised vol
14.77624%
Beta
0.142693
HHI
787.226197
Top-10 weight
73.480411%
VaR 95%
1.309007%
VaR 99%
2.918584%
Max drawdown
38.208516%
Matched value
82.541453%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| KRYS | REDUCED | 632,005 | 673,505 | -6.16% | 234,897,298 |
| STOK | REDUCED | 3,945,920 | 4,164,120 | -5.24% | 129,110,502 |
| IMNM | REDUCED | 4,911,590 | 5,558,885 | -11.64% | 104,076,592 |
| NRIX | REDUCED | 4,073,787 | 7,732,808 | -47.32% | 98,830,073 |
| ABSI | REDUCED | 6,739,675 | 8,253,316 | -18.34% | 78,112,833 |
| ANNX | REDUCED | 11,869,877 | 14,549,768 | -18.42% | 67,776,998 |
| RGNX | UNCHANGED | 4,368,804 | 4,368,804 | 0.0% | 52,338,272 |
| STTK | ADDED | 6,892,033 | 5,539,724 | 24.41% | 47,830,709 |
| NGNE | REDUCED | 1,412,199 | 1,459,599 | -3.25% | 44,413,659 |
| BEAM | REDUCED | 1,164,259 | 1,237,659 | -5.93% | 39,957,369 |
| AGMB | ADDED | 2,733,926 | 156,250 | 1649.71% | 35,486,359 |
| FATE | UNCHANGED | 12,872,946 | 12,872,946 | 0.0% | 34,756,954 |
| IDYA | ADDED | 640,202 | 521,117 | 22.85% | 23,860,329 |
| SLN | UNCHANGED | 2,164,777 | 2,164,777 | 0.0% | 23,769,251 |
| COGT | REDUCED | 503,321 | 688,036 | -26.85% | 19,478,523 |
| SLDB | REDUCED | 1,948,695 | 2,011,895 | -3.14% | 19,467,463 |
| NUVB | REDUCED | 3,031,009 | 3,153,256 | -3.88% | 17,216,131 |
| CLDX | ADDED | 433,921 | 261,508 | 65.93% | 16,146,200 |
| CLYM | NEW | 1,226,330 | - | - | 15,991,343 |
| BMRN | ADDED | 265,169 | 173,859 | 52.52% | 15,172,970 |
| XENE | REDUCED | 229,374 | 262,674 | -12.68% | 13,845,015 |
| ZYME | UNCHANGED | 491,654 | 491,654 | 0.0% | 12,851,836 |
| ADCT | REDUCED | 11,526,710 | 15,470,502 | -25.49% | 12,333,580 |
| AURA | NEW | 1,666,667 | - | - | 11,833,336 |
| ODTX | NEW | 425,000 | - | - | 7,951,750 |
| LIVN | REDUCED | 93,154 | 108,354 | -14.03% | 7,660,053 |
| CBLL | UNCHANGED | 386,786 | 386,786 | 0.0% | 7,522,988 |
| DBVT | REDUCED | 410,440 | 491,340 | -16.47% | 6,731,216 |
| INSM | NEW | 51,234 | - | - | 5,462,569 |
| PRME | REDUCED | 1,389,632 | 1,590,832 | -12.65% | 5,127,742 |
| ATRA | UNCHANGED | 441,701 | 441,701 | 0.0% | 5,070,727 |
| EPRX | REDUCED | 611,400 | 700,000 | -12.66% | 4,041,354 |
| ORIC | REDUCED | 362,010 | 415,710 | -12.92% | 3,920,568 |
| ARDX | REDUCED | 641,750 | 733,350 | -12.49% | 3,272,925 |
| IVVD | REDUCED | 2,597,759 | 2,648,659 | -1.92% | 2,266,285 |
| PLRX | UNCHANGED | 772,126 | 772,126 | 0.0% | 880,224 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| - | SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 237,110,060 | 15.92 | 4311092.0 | |
| KRYS | REDUCED | KRYSTAL BIOTECH INC | COM | 501147102 | 234,897,298 | 15.77 | 632005.0 |
| STOK | REDUCED | STOKE THERAPEUTICS INC | COM | 86150R107 | 129,110,502 | 8.67 | 3945920.0 |
| IMNM | REDUCED | IMMUNOME INC | COM | 45257U108 | 104,076,592 | 6.99 | 4911590.0 |
| NRIX | REDUCED | NURIX THERAPEUTICS INC | COM | 67080M103 | 98,830,073 | 6.64 | 4073787.0 |
| ABSI | REDUCED | ABSCI CORPORATION | COM | 00091E109 | 78,112,833 | 5.24 | 6739675.0 |
| ANNX | REDUCED | ANNEXON INC | COM | 03589W102 | 67,776,998 | 4.55 | 1.1869877E7 |
| RGNX | UNCHANGED | REGENXBIO INC | COM | 75901B107 | 52,338,272 | 3.51 | 4368804.0 |
| STTK | ADDED | SHATTUCK LABS INC | COM | 82024L103 | 47,830,709 | 3.21 | 6892033.0 |
| NGNE | REDUCED | NEUROGENE INC | COM | 64135M105 | 44,413,659 | 2.98 | 1412199.0 |
| BEAM | REDUCED | BEAM THERAPEUTICS INC | COM | 07373V105 | 39,957,369 | 2.68 | 1164259.0 |
| AGMB | ADDED | AGOMAB THERAPEUTICS NV | SPONSORED ADS | 00860C102 | 35,486,359 | 2.38 | 2733926.0 |
| FATE | UNCHANGED | FATE THERAPEUTICS INC | COM | 31189P102 | 34,756,954 | 2.33 | 1.2872946E7 |
| IDYA | ADDED | IDEAYA BIOSCIENCES INC | COM | 45166A102 | 23,860,329 | 1.6 | 640202.0 |
| SLN | UNCHANGED | SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 23,769,251 | 1.6 | 2164777.0 |
| COGT | REDUCED | COGENT BIOSCIENCES INC | COM | 19240Q201 | 19,478,523 | 1.31 | 503321.0 |
| SLDB | REDUCED | SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 19,467,463 | 1.31 | 1948695.0 |
| NUVB | REDUCED | NUVATION BIO INC | COM CL A | 67080N101 | 17,216,131 | 1.16 | 3031009.0 |
| CLDX | ADDED | CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 16,146,200 | 1.08 | 433921.0 |
| CLYM | NEW | CLIMB BIO INC | COM | 28658R106 | 15,991,343 | 1.07 | 1226330.0 |
| - | ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 15,302,483 | 1.03 | 7392504.0 | |
| BMRN | ADDED | BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 15,172,970 | 1.02 | 265169.0 |
| XENE | REDUCED | XENON PHARMACEUTICALS INC | COM | 98420N105 | 13,845,015 | 0.93 | 229374.0 |
| ZYME | UNCHANGED | ZYMEWORKS INC | COM | 98985Y108 | 12,851,836 | 0.86 | 491654.0 |
| ADCT | REDUCED | ADC THERAPEUTICS SA | SHS | H0036K147 | 12,333,580 | 0.83 | 1.152671E7 |
| AURA | NEW | AURA BIOSCIENCES INC | COM | 05153U107 | 11,833,336 | 0.79 | 1666667.0 |
| ODTX | NEW | ODYSSEY THERAPEUTICS INC | COMMON STOCK | 67613T104 | 7,951,750 | 0.53 | 425000.0 |
| LIVN | REDUCED | LIVANOVA PLC | SHS | G5509L101 | 7,660,053 | 0.51 | 93154.0 |
| - | ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 7,634,001 | 0.51 | 88964.0 | |
| CBLL | UNCHANGED | CERIBELL INC | COM | 15678C102 | 7,522,988 | 0.51 | 386786.0 |
| DBVT | REDUCED | DBV TECHNOLOGIES S A | SPONSORED ADS | 23306J309 | 6,731,216 | 0.45 | 410440.0 |
| INSM | NEW | INSMED INC | COM PAR $.01 | 457669307 | 5,462,569 | 0.37 | 51234.0 |
| PRME | REDUCED | PRIME MEDICINE INC | COM | 74168J101 | 5,127,742 | 0.34 | 1389632.0 |
| ATRA | UNCHANGED | ATARA BIOTHERAPEUTICS INC | COM NEW | 046513206 | 5,070,727 | 0.34 | 441701.0 |
| EPRX | REDUCED | EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | 4,041,354 | 0.27 | 611400.0 |
| ORIC | REDUCED | ORIC PHARMACEUTICALS INC | COM | 68622P109 | 3,920,568 | 0.26 | 362010.0 |
| ARDX | REDUCED | ARDELYX INC | COM | 039697107 | 3,272,925 | 0.22 | 641750.0 |
| IVVD | REDUCED | INVIVYD INC | COM | 00534A102 | 2,266,285 | 0.15 | 2597759.0 |
| PLRX | UNCHANGED | PLIANT THERAPEUTICS INC | COM | 729139105 | 880,224 | 0.06 | 772126.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 1,489,508,540 | 39 | 14.77624 | 0.142693 | 38.208516 |
| 2026-03-31 | 2026-05-15 | 1,510,149,045 | 35 | 12.490822 | 0.111049 | 32.669134 |
| 2025-12-31 | 2026-02-17 | 1,357,911,173 | 34 | 14.586383 | 0.127074 | 36.369406 |
| 2025-09-30 | 2025-11-14 | 1,027,815,748 | 40 | 13.134061 | 0.115868 | 33.658091 |
| 2025-03-31 | 2025-05-15 | 1,057,997,904 | 56 | 11.133933 | 0.122598 | 28.123638 |
| 2024-12-31 | 2025-02-14 | 1,434,861,498 | 62 | 11.324676 | 0.131637 | 33.130008 |